Show results for
Refine by
Drug Eluting Stent Equipment Supplied In Usa
17 equipment items found
Manufactured by:Medinol based inTel Aviv, ISRAEL
From crimping through delivery through calcified lesions, expansion and drug elution, drug-eluting stents endure substantial mechanical and chemical stress. Inherently brittle, traditional polymer coatings of drug eluting stents have been shown to develop surface ...
by:Tryton Medical, Inc. based inDurham, NORTH CAROLINA (USA)
The Tryton Side Branch Stent is deployed in the side branch artery using a standard single-wire, balloon-expandable stent delivery system. The open architecture of the Tryton stent allows for integration of a conventional drug eluting stent for the main ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
WiZeCell, our proprietary stent design is paradigm shift in cardiovascular stenting. The design’s sixth generation, the EluNIR drug eluting stent, relieves physicians from compromising between vessel conformability, scaffolding integrity, uniform drug distribution and radial support by ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
Novolimus is a metabolite of the drug Sirolimus, a novel mTOR inhibitor macrolytic lactone with anti-proliferative and anti-inflammatory properties developed by Elixir Medical. The macrocyclic lactone drugs represent the most widely utilized drug family for drug-eluting stent applications and ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
The DynamX Drug Eluting Coronary Bioadaptor System is a significant innovation in the treatment of coronary artery disease. Going beyond drug-eluting stents (DES), DynamX represents one of the most significant breakthroughs in implant design in the past 30 ...
Manufactured by:Medinol based inTel Aviv, ISRAEL
Flexx² is based on a tapered spring tip designed to eliminate tip flare out and buckling while enabling simultaneous flexibility and pushability. The entire coronary product line of Medinol builds on Flexx² catheters, including the EluNIR drug eluting stent system and the NC Gallant PTCA ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
Sirolimus is the most widely known mTOR inhibitor with a well-established safety and effectiveness profile in various treatment applications: Drug-eluting stents, Transplant, Oncology. Novolimus and Sirolimus have been studied as part of Elixir Medical’s Clinical Programs. These clinical trials for DynamX™, DESyne®, ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...
Manufactured by:OrbusNeich Medical Company Ltd. based inShatin, N.T., CHINA
The Pro-Healing DES Designed for rapid vessel healing and superior clinical ...
Manufactured by:Becton Dickinson and Company (BD) based inFranklin Lakes, NEW JERSEY (USA)
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current DESs. In addition, Tepha is developing fully absorbable polymer ...
Manufactured by:Freudenberg Medical based inCarpinteria, CALIFORNIA (USA)
A variety of specialized materials are being used in today’s MedTech environment. Many of these materials are only made suitable for the intended finished use by applying a customized surface treatment. These treatments can result in reduced friction, improvement of haptic properties, the introduction of chemical functionalities, and improved medium resistance of the materials. To meet ...
Manufactured by:Invamed based inChampionsGate, FLORIDA (USA)
Atlas is a coronary balloon-expandable CoCr (L605) stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery ...
by:Endomimetics based inBirmingham, ALASKA (USA)
In many medical settings, devices are commonly used to help doctors treat patients. For example, stents are often used to open blocked arteries, repair torn vessels, and even to keep nasal passages from swelling shut after surgery. Unfortunately these devices fail often resulting in additional surgeries and often replacements of the original ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
Manufactured by:Invamed based inChampionsGate, FLORIDA (USA)
Atlas? is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery disease – including acute coronary syndrome acute myocardial infarction or unstable angina and/or concomitant diabetes mellitus – to improve luminal diameter and reduce restenosis within ...
Manufactured by:N8 Medical, LLC based inPark City, UTAH (USA)
Ceragenins are synthetic small molecules that can be manufactured in large scale and, unlike endogenous antimicrobial peptides, are not subject to proteolytic degradation. Over 100 ceragenins have been synthesized to date. Ceragenins consist of a sterol backbone with amino acids and other chemical groups attached to them. These compounds have a net positive charge that is electrostatically ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Umirolimus, a macrocyclic triene lactone Rapamycin derivative, is powerful immunosuppressant and anti-inflammatory agent. Umirolimus has highly lipophilicity and can be used agent-eluting stent (DES) ...